Insiders Trades

★ Sign in to follow

AC

Atul Chopra

US·SEC (Form 4)

Idera Pharmaceuticals, Inc.

Cumul. flow

Total declarations

66

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (66 ops.)

€376k

Latest filing published 18 May 2023 for Idera Pharmaceuticals, INC., €8,617.

Filing timeline

BuySale

Atul Chopra

Insider track record

Disclosed buys

0

Disclosed sells

66

Signal history

Atul Chopra: trading record in brief

All filings by Atul Chopra on record concern Idera Pharmaceuticals, Inc. Over a trading history stretching from 11 May 2023 to 17 May 2023, the count stands at 66 filings.

No open-market purchase appears, only 66 sales worth €376k.

The record was last updated on 18 May 2023 with an open-market sale (€8,617) in Idera Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Atul Chopra

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Idera Pharmaceuticals, Inc. (US)

Declarations66 total

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

9,369 USD5SEC

6,645 shares@ US$1.412.3% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:1

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

12,026 USD5SEC

8,469 shares@ US$1.422.9% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:2

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

1,745 USD5SEC

1,220 shares@ US$1.430.4% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:3

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

4,851 USD5SEC

3,369 shares@ US$1.441.2% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:4

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

1,016 USD5SEC

701 shares@ US$1.450.2% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:5

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

70 USD5SEC

48 shares@ US$1.460.0% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:6

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

74 USD5SEC

50 shares@ US$1.470.0% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:7

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

462 USD5SEC

312 shares@ US$1.480.1% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:8

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

2,108 USD5SEC

1,415 shares@ US$1.490.5% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:9

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

8,255 USD5SEC

5,503 shares@ US$1.502.0% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:10

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

21,360 USD6SEC

14,146 shares@ US$1.515.2% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:11

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

13,773 USD5SEC

9,061 shares@ US$1.523.4% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:12

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

18,242 USD5SEC

11,923 shares@ US$1.534.5% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:13

▼

10% OwnerExecutives15 May 2023Idera Pharmaceuticals, Inc.

13,378 USD5SEC

8,687 shares@ US$1.543.3% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:14

▼

10% OwnerExecutives16 May 2023Idera Pharmaceuticals, Inc.

5,230 USD5SEC

3,736 shares@ US$1.401.3% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:15

▼

10% OwnerExecutives16 May 2023Idera Pharmaceuticals, Inc.

15,317 USD5SEC

10,863 shares@ US$1.413.8% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:16

▼

10% OwnerExecutives16 May 2023Idera Pharmaceuticals, Inc.

11,651 USD5SEC

8,205 shares@ US$1.422.9% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:17

▼

10% OwnerExecutives16 May 2023Idera Pharmaceuticals, Inc.

13,774 USD5SEC

9,632 shares@ US$1.433.4% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:18

▼

10% OwnerExecutives17 May 2023Idera Pharmaceuticals, Inc.

337 USD5SEC

257 shares@ US$1.310.1% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:19

▼

10% OwnerExecutives17 May 2023Idera Pharmaceuticals, Inc.

1,385 USD5SEC

1,049 shares@ US$1.320.3% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:20

▼

10% OwnerExecutives17 May 2023Idera Pharmaceuticals, Inc.

20,179 USD5SEC

15,172 shares@ US$1.335.0% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:21

▼

10% OwnerExecutives17 May 2023Idera Pharmaceuticals, Inc.

8,283 USD5SEC

6,181 shares@ US$1.342.0% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:22

▼

10% OwnerExecutives17 May 2023Idera Pharmaceuticals, Inc.

811 USD5SEC

601 shares@ US$1.350.2% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:23

▼

10% OwnerExecutives17 May 2023Idera Pharmaceuticals, Inc.

2,110 USD5SEC

1,540 shares@ US$1.370.5% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000555:24

▼

10% OwnerExecutives12 May 2023Idera Pharmaceuticals, Inc.

10,815 USD5SEC

7,162 shares@ US$1.512.6% of flowCommon Stock, $0.001 per shareSEC:0001185185-23-000553:1

25 of 66 declarations